Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Ravaud

Showing results (411-420 of 457) with videos related to

Pageof 46
Sort By:
Arthritis and Rheumatism|January 1, 2008
Maintenance of infliximab treatment in ankylosing spondylitis: results of a one-year randomized controlled trial comparing systematic versus on-demand treatmentMaxime Breban, Philippe Ravaud, Pascal Claudepierre, et al.
Rheumatology (Oxford, England)|November 22, 2024
Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohortYann Nguyen, Gabriel Baron, Naima Hamamouche, et al.
Annals of the Rheumatic Diseases|May 5, 2018
Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitidesBenjamin Terrier, Christian Pagnoux, Élodie Perrodeau, et al.
Frontiers in Immunology|December 11, 2023
More rapid blood interferon α2 decline in fatal versus surviving COVID-19 patientsCandie Joly, Delphine Desjardins, Raphael Porcher, et al.
The New England Journal of Medicine|November 6, 2014
Rituximab versus azathioprine for maintenance in ANCA-associated vasculitisLoïc Guillevin, Christian Pagnoux, Alexandre Karras, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 19, 2015
Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapyChristian Pagnoux, Thomas Quéméneur, Jacques Ninet, et al.
Annals of the Rheumatic Diseases|February 25, 2011
EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndromeRaphaèle Seror, Philippe Ravaud, Xavier Mariette, et al.
Plos One|May 30, 2013
Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohortJacques-Eric Gottenberg, Raphaèle Seror, Corinne Miceli-Richard, et al.
Clinical and Experimental Rheumatology|April 7, 2016
Rituximab versus azathioprine for ANCA-associated vasculitis maintenance therapy: impact on global disability and health-related quality of lifeGrégory Pugnet, Christian Pagnoux, Benjamin Terrier, et al.
Autoimmunity Reviews|August 19, 2015
Description of 214 cases of autoimmune congenital heart block: Results of the French neonatal lupus syndromeKateri Levesque, Nathalie Morel, Alice Maltret, et al.
Pageof 46

Showing results (411-420 of 457) with videos related to

Sort By:
Pageof 46
Arthritis and Rheumatism|January 1, 2008
Maintenance of infliximab treatment in ankylosing spondylitis: results of a one-year randomized controlled trial comparing systematic versus on-demand treatmentMaxime Breban, Philippe Ravaud, Pascal Claudepierre, et al.
Rheumatology (Oxford, England)|November 22, 2024
Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohortYann Nguyen, Gabriel Baron, Naima Hamamouche, et al.
Annals of the Rheumatic Diseases|May 5, 2018
Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitidesBenjamin Terrier, Christian Pagnoux, Élodie Perrodeau, et al.
Frontiers in Immunology|December 11, 2023
More rapid blood interferon α2 decline in fatal versus surviving COVID-19 patientsCandie Joly, Delphine Desjardins, Raphael Porcher, et al.
The New England Journal of Medicine|November 6, 2014
Rituximab versus azathioprine for maintenance in ANCA-associated vasculitisLoïc Guillevin, Christian Pagnoux, Alexandre Karras, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 19, 2015
Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapyChristian Pagnoux, Thomas Quéméneur, Jacques Ninet, et al.
Annals of the Rheumatic Diseases|February 25, 2011
EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndromeRaphaèle Seror, Philippe Ravaud, Xavier Mariette, et al.
Plos One|May 30, 2013
Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohortJacques-Eric Gottenberg, Raphaèle Seror, Corinne Miceli-Richard, et al.
Clinical and Experimental Rheumatology|April 7, 2016
Rituximab versus azathioprine for ANCA-associated vasculitis maintenance therapy: impact on global disability and health-related quality of lifeGrégory Pugnet, Christian Pagnoux, Benjamin Terrier, et al.
Autoimmunity Reviews|August 19, 2015
Description of 214 cases of autoimmune congenital heart block: Results of the French neonatal lupus syndromeKateri Levesque, Nathalie Morel, Alice Maltret, et al.
Pageof 46